Stay updated on Combining Pembrolizumab and PEG-Intron for Cholangiocarcinoma Clinical Trial

Sign up to get notified when there's something new on the Combining Pembrolizumab and PEG-Intron for Cholangiocarcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Combining Pembrolizumab and PEG-Intron for Cholangiocarcinoma Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    New operating-status notice and v3.2.0 release; prior v3.1.0 revision removed.
    Difference
    3%
    Check dated 2025-10-05T04:38:59.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Summary
    Upgrade from v3.0.2 to v3.1.0. This is a version/revision update; no other content changes are indicated.
    Difference
    0.1%
    Check dated 2025-09-28T02:41:21.000Z thumbnail image
  6. Check
    45 days ago
    Change Detected
    Summary
    Version bump: v3.0.2 replaces v3.0.1. The 'Back to Top' element was removed.
    Difference
    0.2%
    Check dated 2025-09-13T17:46:07.000Z thumbnail image
  7. Check
    52 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to 3.0.1, indicating a revision in the content. There are no significant changes to core content or other important elements.
    Difference
    0.2%
    Check dated 2025-09-06T15:29:21.000Z thumbnail image
  8. Check
    59 days ago
    Change Detected
    Summary
    The web page has updated its facility name and location details, specifically emphasizing the treatment options for Cholangiocarcinoma, including pembrolizumab and peginterferon alfa-2b.
    Difference
    2%
    Check dated 2025-08-30T12:11:53.000Z thumbnail image
  9. Check
    74 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.11 to version 2.16.12.
    Difference
    0.1%
    Check dated 2025-08-16T04:51:17.000Z thumbnail image

Stay in the know with updates to Combining Pembrolizumab and PEG-Intron for Cholangiocarcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Combining Pembrolizumab and PEG-Intron for Cholangiocarcinoma Clinical Trial page.